Research
Hormonal
Difficulty falling asleep (DFA) and unrefreshing sleep are significant predictors of metabolic syndrome development, independent of loud snoring and AHI.
Pay attention to how long it takes you to fall asleep and whether you feel rested. These specific sleep quality issues are linked to a higher risk of metabolic syndrome. Addressing these symptoms with a healthcare provider may help mitigate this risk.
GoodSupportsMEDIUM confidence
Specific symptoms of insomnia (difficulty falling asleep [DFA] and 'unrefreshing' sleep)... were significant predictors of the development of metabolic syndrome.
Why this rating
Prospective cohort study with multivariate adjustment.
Source
Sleep Symptoms Predict the Development of the Metabolic Syndrome
Wendy Troxel et al. · SLEEP · 2010
DOI 10.1093/sleep/33.12.1633
cohort · n=812Cited 277×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →